Full approval from the US Food and Drug Administration of the Pfizer/BioNTech vaccine is “imminent,” a senior federal official told CNN last week. Another official said the approval could come in the next two weeks or as early as today.
Once it happens, it could help allay concerns for those who are vaccine hesitant, as all three vaccines available in the US have so far been distributed under emergency use authorization.
The approval could also help businesses, schools and states enforce vaccine mandates, experts have said. Such mandates could help quell the ever-growing number of cases, especially in states that are experiencing a lack of available intensive care unit beds.
